omniture

China Medical Technologies to Announce Results for the Second Fiscal Quarter Ended September 30, 2010 on November 17, 2010

2010-11-08 16:09 1310

BEIJING, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the second fiscal quarter ended September 30, 2010 before the U.S. market opens on November 17, 2010. The Company's 2010 fiscal year ends on March 31, 2011.

The Company will also provide outlook for the third fiscal quarter ending December 31, 2010 as well as the fiscal year ending March 31, 2011 in the results announcement.

The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on November 17, 2010 (9:00 p.m. Beijing/Hong Kong time on November 17, 2010).  

Conference Call

The dial-in details for the live conference call are as follows:

- U.S. Toll Free Number 1-800-591-6923


- International Dial-in Number 1-617-614-4907


Passcode: CMEDCALL



A live webcast of the conference call will be available on http://ir.chinameditech.com.

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on November 18, 2010.  The dial-in details for the replay are as follows:

- U.S. Toll Free Number 1-888-286-8010


- International Dial-in Number 1-617-801-6888


Passcode: 10798661



About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology as well as Enhanced Chemiluminescence Immunoassay (ECLIA) technology, an immunodiagnostic technology to develop, manufacture and distribute diagnostic products for the detection of various cancers, diseases and disorders. The Company generates all revenues in China by selling diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales force and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com.

Contact




Winnie Yam


Tel: 852-2511-9808


Email: IR@chinameditech.com





Source: China Medical Technologies, Inc.
Related Stocks:
NASDAQ:CMED
collection